Sean Dodge
Stock Analyst at RBC Capital
(2.14)
# 2,673
Out of 4,829 analysts
133
Total ratings
32.99%
Success rate
-2.29%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $4.13 | +45.28% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.89 | +21.11% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $148.99 | +81.22% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.11 | +68.78% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $133.96 | +96.33% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $9.05 | +87.85% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $25.62 | +24.90% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $9.99 | -39.94% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $90.44 | +16.10% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $13.13 | +29.47% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $40.01 | -15.02% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $24.81 | -43.57% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.32 | +131.48% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.02 | +11.91% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $14.27 | -1.89% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $170.90 | -80.69% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.64 | +10,875.61% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $4.13
Upside: +45.28%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.89
Upside: +21.11%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $148.99
Upside: +81.22%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.11
Upside: +68.78%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $133.96
Upside: +96.33%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.05
Upside: +87.85%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $25.62
Upside: +24.90%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $9.99
Upside: -39.94%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $90.44
Upside: +16.10%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $13.13
Upside: +29.47%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $40.01
Upside: -15.02%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $24.81
Upside: -43.57%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.32
Upside: +131.48%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $25.02
Upside: +11.91%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $14.27
Upside: -1.89%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $170.90
Upside: -80.69%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.64
Upside: +10,875.61%